TrialCancer research communications2023

On the Choice of Longitudinal Models for the Analysis of Antitumor Efficacy in Mouse Clinical Trials of Patient-derived Xenograft Models.

Hélène Savel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.